Results 1 to 10 of about 21,694,813 (356)

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review

open access: yesPharmaceuticals, 2023
Antibiotics have revolutionized medicine, saving countless lives since their discovery in the early 20th century. However, the origin of antibiotics is now overshadowed by the alarming rise in antibiotic resistance.
Ghazala Muteeb   +3 more
semanticscholar   +1 more source

Quantifying the impact of the COVID-19 pandemic on clinical trial screening rates over time in 37 countries

open access: yesTrials, 2023
The COVID-19 pandemic has had an unprecedented and disruptive impact on people’s health and lives worldwide. In addition to burdening people’s health in the short-term in the form of infection, illness, and mortality, there has been an enormous negative ...
Kelsey McDonald   +6 more
doaj   +1 more source

Human disease models in drug development

open access: yesNature Reviews Bioengineering, 2023
Biomedical research is undergoing a paradigm shift towards approaches centred on human disease models owing to the notoriously high failure rates of the current drug development process.
Anna Loewa, James J Feng, S. Hedtrich
semanticscholar   +1 more source

Cyclic Peptides for Drug Development.

open access: yesAngewandte Chemie, 2023
Cyclic peptides are fascinating molecules abundantly found in nature and exploited as molecular format for drug development as well as other applications, ranging from research tools to food additives.
Xinjian Ji   +2 more
semanticscholar   +1 more source

The case against censoring of progression-free survival in cancer clinical trials – A pandemic shutdown as an illustration

open access: yesBMC Medical Research Methodology, 2022
Background Missing data may lead to loss of statistical power and introduce bias in clinical trials. The Covid-19 pandemic has had a profound impact on patient health care and on the conduct of cancer clinical trials.
Corinne Jamoul   +6 more
doaj   +1 more source

New frontiers in immune checkpoint B7-H3 (CD276) research and drug development

open access: yesMolecular Cancer, 2023
B7-H3 (CD276), a member of the B7 family of proteins, is a key player in cancer progression. This immune checkpoint molecule is selectively expressed in both tumor cells and immune cells within the tumor microenvironment.
A. Getu   +5 more
semanticscholar   +1 more source

PP2A in LepR+ mesenchymal stem cells contributes to embryonic and postnatal endochondral ossification through Runx2 dephosphorylation

open access: yesCommunications Biology, 2021
Yen et al use tissue-specific PP2A knockout mice to show that PP2A in LepR positive mesenchymal stem cells positively regulates endochondral ossification. They find that PP2A dephosphorylates Runx2 and BRD4, thereby playing a major role in positively and
Yu-Ting Yen   +3 more
doaj   +1 more source

Alzheimer's disease drug development pipeline: 2023

open access: yesAlzheimer's & Dementia, 2023
Drugs that prevent the onset, slow progression, or improve cognitive and behavioral symptoms of Alzheimer's disease (AD) are needed.
J. Cummings   +5 more
semanticscholar   +1 more source

Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response

open access: yesNature Communications, 2021
Microsatellite instability (MSI), caused by deficiency of the DNA mismatch repair system, has been associated with improved response to immune checkpoint blockade (ICB).
Yu-Ting Yen   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy